We now demonstrate that human Cdt1 has a separable essential mitotic function. Cdt1 localizes to kinetochores during mitosis through interaction with the Hec1 component of the Ndc80 complex. G2-specific depletion of Cdt1 arrests cells in late prometaphase owing to abnormally unstable kinetochore-microtubule (kMT) attachments and Mad1-dependent spindle-assembly-checkpoint activity. Cdt1 binds a unique loop extending from the rod domain of Hec1 that we show is also required for kMT attachment. Mutation of the loop domain prevents Cdt1 kinetochore localization and arrests cells in prometaphase. Super-resolution fluorescence microscopy indicates that Cdt1 binding to the Hec1 loop domain promotes a microtubule-dependent conformational change in the Ndc80 complex in vivo. These results support the conclusion that Cdt1 binding to Hec1 is essential for an extended Ndc80 configuration and stable kMT attachment.
The cell-division cycle is the process of complete and precise duplication of the entire genome in S phase followed by accurate chromosome segregation in mitosis. The formation and stability of kMT attachments during mitosis depends on the Ndc80 complex, Ndc80 (hsHec1), Nuf2, Spc24 and Spc25 (refs 1,2) . Hec1/Nuf2 and Spc24/25 form dimers respectively that are tethered together at the carboxy termini of Hec1/Nuf2 and the amino termini of Spc24/Spc25 by long αhelical coiled-coil rod domains. In the middle of the rod domain is a 'hinge' site produced by a ∼40-amino-acid loop in Hec1 that is thought to play a key role in microtubule-binding dynamics and attachment 3 . Binding partners for the loop region of yeast Hec1/Ndc80 proteins have been identified 4, 5 , but the partners and function of the unique Hec1 loop domain at metazoan kinetochores remains unknown. In this study, we identify the Cdt1 protein as an essential partner for Ndc80 dynamic function through interaction with the Hec1 loop domain.
Cdt1 is required for DNA replication origin licensing, the initial step in genome duplication, which occurs in G1 phase 6, 7 . Proteins involved in origin licensing are not strictly DNA replication factors, however; some licensing proteins have functions in transcription 8,9 , the 4) or an siRNA-resistant form of Cdt1 ('Cdt1 res ' lanes 5 and 6) were synchronized as in b and transfected with either control siRNA targeting GFP (lanes 1 and 2) or with cdt1 siRNA (lanes [3] [4] [5] [6] . Cells were released from early S phase into nocodazole (Noc.) for 10 h and then either collected (0 h) or released for 2 h into G1 phase, and Cdt1 protein levels were analysed by immunoblotting. (e) Flow cytometric analysis of DNA content of the cells in d. Uncropped images of blots are shown in Supplementary Fig. S9 .
containing control short interfering RNA (siRNA) or cdt1 siRNA. As expected, control cells had very low amounts of Cdt1 in S phase, and Cdt1 re-accumulated in G2 (Fig. 1c, lanes 1-5) . Synchronized cells treated with cdt1 siRNA could not re-accumulate Cdt1 in G2, however (Fig. 1c, lanes 7-10) . (Cdt1 is phosphorylated in G2 by stress MAP kinases 17, 18 .) Cdt1 depletion during S phase caused no delay in S-phase progression ( Supplementary Fig. S1a,b ), and by 9 h after release, both control and Cdt1-depleted cells exhibited normal chromosome condensation and/or nuclear envelope breakdown (for example, Fig. 2a and data not shown). This unique experimental approach allowed us to generate cells that underwent a normal G1 and S phase but lacked Cdt1 during G2 and M phase. We then investigated the ability of Cdt1-depleted cells to transit mitosis to G1 after a nocodazole arrest and release ( Fig. 1d,e ). Control cells completed cell division, but Cdt1-depleted cells remained arrested with G2 DNA content ( Fig. 1e , control siRNA versus cdt1 siRNA). A cell line stably expressing normal Cdt1 with synonymous mutations in the siRNA target site was fully capable of mitotic progression ( Fig. 1d,e ). Unphosphorylatable Cdt1 (ref. 18 ) also complemented the cell-division phenotype of Cdt1-depleted cells ( Supplementary Fig. S1c,d ). Cells depleted of Cdt1 during S phase did not accumulate phosphorylated H2AX by the subsequent G2, a marker of DNA damage, whereas siRNA transfection of asynchronous cultures to deplete either Cdt1 or another licensing protein, Orc6, resulted in the accumulation of phospho-H2AX-positive foci, presumably from incomplete replication and fork collapse ( Supplementary Fig. S1e ).
Most of the synchronized Cdt1-depleted cells arrested just before metaphase with most chromosomes positioned near the spindle equator. A smaller fraction of cells arrested in prometaphase ( Fig. 2a,b and Supplementary Fig. S2a,b ). In addition to Cdt1 depletion in synchronized cells, we also microinjected purified anti-Cdt1 antibody ( Supplementary Fig. S2c ) into HeLa cells expressing GFP-tagged histone H2B during prophase or early prometaphase and conducted live-cell imaging (n = 27). Anti-Cdt1 antibody induced both a severe
Buffer-injected
Anti-Cdt1-antibody-injected delay in chromosome congression and an arrest near metaphase for the entire ∼3 h duration of imaging ( Fig. 2d,e ). Control bufferinjected cells (n = 15) or control anti-mouse IgG-injected cells (n = 8) executed mitosis normally (Fig. 2c ,e and Supplementary Movies S1 and S2). Anti-Cdt1 injection during late prometaphase or metaphase (n = 10) resulted in 70% of the cells remaining arrested in that stage for up to 8 h . During this period, cells progressively lost chromosome alignment but did not divide ( Supplementary  Fig. S2d and Movie S4).
Cdt1 localizes to mitotic kinetochores through interaction with the Hec1 component of Ndc80
The late-prometaphase arrest of Cdt1-depleted cells prompted us to examine Cdt1 localization in mitosis. Remarkably, we detected endogenous Cdt1 co-localization with a known kinetochore protein, Hec1, in prometaphase in both nocodazole-treated PTK2 and HeLa cells ( Fig. 3a , and data not shown). Cdt1 depletion by siRNA treatment in S phase eliminated detectable anti-Cdt1 kinetochore staining ( Supplementary Fig. S3a ). We observed no kinetochore localization of the Cdt1 inhibitor geminin 19, 20 at any stage of mitosis ( Supplementary  Fig. S3b ). A second anti-Cdt1 antibody also detected endogenous Cdt1 at kinetochores in LLCPK1 cells ( Fig. 3b-f ). Thus, Cdt1 localizes to kinetochores in control cells at a time coincident with the stage at which Cdt1-depleted cells arrest. In a search for Cdt1-interacting proteins by two-hybrid screening in yeast, we identified multiple independent clones containing portions of human Hec1 ( Supplementary Fig. S4a ); the shortest contained Hec1 amino acids 306-642 ( Supplementary Fig. S4a,b ). To determine whether Cdt1 and Hec1 interact biochemically, we incubated immobilized bacterially expressed GST-Cdt1 with lysates of asynchronous HeLa cells. Endogenous Hec1 associated with GST-Cdt1 but not GST alone ( Fig. 4a ). Nuf2 was also retrieved from cell lysates by GST-Cdt1 ( Fig. 4a ), indicating that Cdt1 can associate with the Ndc80 complex, possibly through a direct interaction with Hec1 (based on interaction of the fusions in yeast). We further confirmed the interaction between Cdt1 and Hec1 by reciprocal co-immunoprecipitation of the endogenous proteins ( Fig. 4b,c ).
To determine whether Hec1 recruits Cdt1 to kinetochores in mitosis, we stained for endogenous Cdt1 in Hec1-depleted PTK2 cells. Hec1 depletion resulted in a profound loss of Cdt1 at kinetochores in nocodazole-treated prometaphase (Fig. 4d , bottom panel and Fig. 4e ) and metaphase cells ( Supplementary Fig. S4c , bottom panel) when compared with controls ( Fig. 4d and Supplementary Fig. S4c , top panels) . We observed no Cdt1 decrease in extracts of Hec1depleted cells ( Supplementary Fig. S4d ), and Cdt1 depletion had no effect on Hec1 expression or kinetochore localization ( Supplementary  Fig. S4e ). Other kinetochore proteins, including components of the Mis12 complex, Knl1 and the Zwint1-RZZ complex, were also localized normally in Cdt1-depleted cells ( Fig. 2a and Supplementary Figs S4e and S8a,b).
Similarly to Cdt1, ORC is essential for replication origin licensing, and the Orc2 and Orc6 subunits in particular have also been reported to localize to centromeres or kinetochores 13, 14 . ORC is required for Cdt1 chromatin localization in G1 (ref. 21) , and the Orc6 subunit associates with Cdt1 ( Supplementary Fig. S5a ; ref. 22) . We found that, as for Cdt1, Orc6 immunofluorescence intensity at kinetochores was also substantially reduced in Hec1-depleted cells ( Fig. 4f ,g). Orc6 depletion had no effect on Hec1 or Cdt1 kinetochore localization, however ( Supplementary Fig. S5d,e ). Interestingly, depletion of Cdt1 resulted in a ∼50% decrease in the intensity of Orc6 kinetochore staining ( Supplementary Fig. S5b,c) . To compare the reported mitotic defects induced by Orc6 inhibition 14 to those produced by depleting Cdt1, we first calculated the mitotic indices of asynchronous cells depleted of Orc6. Orc6 is not degraded in S phase like Cdt1, so we could not employ the same synchronization strategy to remove Orc6 only before mitosis. Orc6 depletion caused a ∼50% increase in the number of mitotic cells when compared with controls ( Supplementary  Fig. S5f ) by producing a fourfold increase in the number of telophase cells ( Supplementary Fig. S5g ). In addition, cells depleted of Orc6 exhibited normal cold-stable kMTs ( Supplementary Fig. S5h ). These observations support the conclusion 14,23 that Orc6 has a role late in mitosis during cytokinesis distinct from the role of Cdt1 during prometaphase or metaphase.
The Hec1 loop domain is required for Cdt1 localization and anaphase onset
Our two-hybrid analysis indicated that the Cdt1-binding region of Hec1 includes a short interruption in the coiled-coil pattern postulated to be a flexible 'loop' 3 ( Supplementary Fig. S4a,b ). To determine whether this domain is required for Cdt1 binding, we replaced the normal loop sequence with a sequence of alternative amino acids of similar length, which we term 'Hec1 Loop MUT ' (Fig. 5a ). A similar sequence provides a flexible linker in a well-studied GFP-PCNA fusion 24 . Both wild-type Hec1 and Hec1 Loop MUT were tagged with GFP at their C termini. Strikingly, Hec1 Loop MUT -GFP failed to co-immunoprecipitate with Cdt1, whereas wild-type Hec1-GFP bound Cdt1 readily (Fig. 5b , compare lanes 4 and 5). Both GFP-tagged wild-type and Loop MUT Hec1 localized normally to kinetochores in PTK2 and HeLa cells ( Fig. 5c,e ). We then tested Cdt1 localization in PTK2 cells depleted of endogenous Hec1 but expressing siRNA-resistant versions of wild-type Hec1-GFP or Hec1 Loop MUT -GFP. Cdt1 localized to kinetochores normally in cells expressing wild-type Hec1-GFP ( Fig. 5c , top panel), but was strikingly undetectable at kinetochores in cells expressing Hec1 Loop MUT -GFP (Fig. 5c , bottom panel). Orc6 kinetochore targeting was also dependent on the Hec1 loop ( Fig. 5d ). S6a ). Live-cell imaging of cells expressing only Hec1 Loop MUT -GFP also revealed a 100% mitotic arrest phenotype (n = 29). The phenotypes of Hec1Loop MUT -GFP cells were more severe than Cdt1-depleted cells, which could be due to quantitative differences in the effectiveness of the different siRNAs in synchronized versus asynchronous cultures, defects in spindle structure from Hec1 perturbation or to other functions of the loop apart from Cdt1 binding. The range of phenotypes in both circumstances was similar, however ( Supplementary Fig. S6c,d) , indicating that the Hec1 Loop MUT phenotype might be largely explained by failure to recruit Cdt1 to kinetochores.
The absence of Cdt1 at kinetochores causes defective kMT attachment and Mad1-dependent arrest
These phenotypes prompted us to probe the spindle-assemblycheckpoint status of arrested cells. In Cdt1-depleted cells, kinetochore localization of the checkpoint protein, Mad1, on aligned chromosomes was 5.2-fold higher than in control cells (Fig. 6a , top and middle panels, and Fig. 6b ). We measured a similar 4.5-fold Mad1 increase at aligned kinetochores in cells expressing Hec1 Loop MUT -GFP 100  90  80  70  60  50  40  30  20 versus wild-type Hec1-GFP (Fig. 6a, bottom panel, and Fig. 6c ). Kinetochore localization of another checkpoint protein, BubR1, was unaltered by Cdt1 depletion (data not shown). To determine whether Mad1 recruitment fully accounts for the mitotic arrest produced by Cdt1 inhibition, we co-depleted Mad1 with Cdt1. As demonstrated previously 25 , control cells depleted of Mad1 alone underwent premature anaphase onset (Fig. 6, compare d with f) . Importantly, co-depletion of Mad1 with Cdt1 bypassed the mitotic arrest of Cdt1-depleted cells (Fig. 6 , compare e with g). We thus conclude that Cdt1 depletion induces persistent Mad1-dependent spindle-assembly-checkpoint signalling. Of further note, synchronized cells co-depleted of both Mad1 and Cdt1 did not produce many anaphase chromosome bridges relative to Mad1-depleted cells. We reasoned that unreplicated DNA segments would not be segregated properly, leading to the production of anaphase chromosome bridges. The absence of increased anaphase bridges reinforces our assertion that Cdt1 is not required during S phase for complete DNA replication. On the other hand, asynchronous cells depleted of either Cdt1 or Orc6 produced many anaphase chromosome bridges ( Supplementary  Fig. S7a,b and data not shown). 28 ) of mean separation between Spc24 and the Hec1 CH domain (9G3 antibody) in synchronized control or Cdt1-depleted mitotic cells (9 h after S-phase release), or in Rod-depleted cells (mitotic metaphase cells selected from an asynchronous population); n = 84, 47 and 54 kinetochore pairs respectively; (control versus cdt1 siRNA) P < 0.001, (control versus rod siRNA) P = 0.31 (not significant). (d) The same as in c, except that Delta values of separation between Nsl1 (Mis12 complex subunit) and the Hec1 CH domain were determined; n = 74, 41 and 60 kinetochore pairs respectively; (control versus cdt1 siRNA) P < 0.001, (control versus rod siRNA) P = 0.86 (not significant). Data are presented as mean ± s.d. The presence of high levels of Mad1 at kinetochores indicated that loss of Cdt1 or mutation of the Hec1 loop produces kMT attachments that are insufficiently robust. We therefore investigated the cold stability of kMTs by chilling cells at late prometaphase or metaphase before fixing them for immunofluorescence analysis. The fluorescence intensity of kMTs after cold treatment for Cdt1-depleted cells or Hec1 Loop MUT -GFP cells was ∼50% of controls (Fig. 7a , top and middle panels, and Supplementary Fig. S7c ). Quantification of kinetochores that made contact with cold-stable spindle microtubules revealed a 77% decrease in the number of kinetochore fibres in Cdt1-depleted cells and an 84% decrease in Hec1 Loop MUT -GFP cells relative to corresponding controls (Fig. 7b ). As another indicator of kMT attachment, we measured the inter-kinetochore (kinetochore-kinetochore) distance of aligned sister kinetochore pairs; ∼1.4 µm for siRNA-transfected controls and ∼1.25 µm for Hec1-depleted cells expressing wild-type Hec1-GFP. In contrast, the kinetochore-kinetochore distance was just 0.96 µm in Cdt1-depleted cells and 1.05 µm in cells expressing Hec1 Loop MUT -GFP (Fig. 7c) . These values correspond to a 50-60% loss of kinetochore stretch because the unstretched kinetochore-kinetochore centromere length is ∼0.7 µm in cells treated with nocodazole 26 . As in Cdt1-depleted cells, there were no discernible changes in the kinetochore localization of most other proteins examined in cells expressing Hec1 Loop MUT -GFP ( Supplementary Fig. S8b ).
To determine whether artificially strengthening microtubule attachments can compensate for Cdt1 loss or mutations in the Hec1 loop domain, we blocked Aurora-B-kinase-mediated Hec1 phosphorylation. Pharmacological Aurora B inhibition or mutation of the 9 phosphorylation sites in the N-terminal Hec1 tail enhances microtubule-binding affinity at this end of the Ndc80 complex 1, 2, [27] [28] [29] [30] . Treating Cdt1-depleted mitotic cells with the Aurora B inhibitor, ZM447439, caused premature anaphase onset similar to control drug-treated cells or Mad1-depleted cells, demonstrating effective Aurora B inhibition ( Supplementary Fig. S7f,g) . We also coupled our synchronization and Cdt1 depletion protocol with expression of the Aurora-B-resistant Hec1 (9A-Hec1-GFP) combined with endogenous Hec1 depletion. The result of this manipulation was identical to that of Aurora B inhibition (data not shown). To determine whether progression to anaphase in these experiments involved stabilization of kMT attachments, we treated cells with the proteasome inhibitor MG132 to prevent anaphase onset and subjected them to the coldstability assay. ZM447439-treated or 9A-Hec1-GFP-expressing cells lacking Cdt1 retained stable kMTs (Fig. 7d,e ). These results indicated that the absence of Cdt1 at kinetochores results in failure to establish and/or maintain sufficiently strong kMT attachments.
Interaction of Cdt1 with the Hec1 loop is required for the normal conformation of the Ndc80 complex at kinetochores of bi-oriented chromosomes
The loop region of Hec1 allows conformational changes within the Ndc80 complex 3 . To determine whether Cdt1 influences this conformation, we employed an in vivo two-colour super-resolution fluorescence microscopy technique by labelling the two ends of the Ndc80 complex (Delta analysis illustrated in Fig. 8a; ref. 26 ). We used the 9G3 antibody, whose epitope in Hec1 resides next to the N-terminal CH domain, an anti-Spc24 antibody to mark the C-terminal region of the Ndc80 complex and a Nsl1 antibody to mark the Mis12 complex, which is about 4 nm inside Spc24 (ref. 26 ; Fig. 8a ). Measurements of the average separation, Delta, between 9G3 and the two other antibodies yielded values of ∼41 and ∼45 nm for kinetochores of aligned chromosomes in control cells at metaphase (Fig. 8c,d) . After Cdt1 depletion, the corresponding Delta values were ∼35 nm and ∼37 nm, respectively (Fig. 8c,d) , values significantly different from controls (P < 0.001). To determine whether these reductions were a general consequence of unstable kMT attachments, we measured Delta following depletion of Rod (a component of the RZZ complex), which, similarly to Cdt1 depletion, produces 50% reduction in kMT stability 31 . Unlike Cdt1 depletion, Delta values for Rod depletion (∼39 nm and ∼45 nm; Fig. 8c,d) were not significantly different from controls (P = 0.31 and P = 0.86, respectively); Rod depletion reduced kinetochore-kinetochore stretch from ∼1.4 µm to 1.15 µm, demonstrating the effectiveness of the siRNA. In nocodazoletreated cells that lack kMTs, the distance between the ends of the Ndc80 complex along the kinetochore-kinetochore axis is short with a Delta value of ∼17 nm (ref. 28 ). We measured Delta values for Cdt1-depleted and nocodazole-treated cells at 19 nm ± 7 nm for Spc24 to 9G3 and 20 nm±8 nm for Nsl to 9G3 (n = 100 sister kinetochore pairs, >5 cells). Taken together, these results indicate that the essential mitotic function of Cdt1 is to bind to the Ndc80 complex at the Hec1 loop and maintain an extended conformation along the lattice of kMTs to stabilize end-on attachments of spindle microtubules to kinetochores.
DISCUSSION

Distinct essential functions for Cdt1 in both G1 and M phases
Using a unique approach to deplete Cdt1 specifically after its replication function is completed, we unequivocally demonstrated an essential and previously unknown mitotic function for human Cdt1 in kMT attachment. This discovery raises the question of why such dual roles would have evolved. One possibility is to ensure orderly progression from S phase to M phase. Cdt1 is degraded while replication is ongoing to avoid re-licensing origins that have already fired 32, 33 . We recently reported a mechanism of Cdt1 stabilization after S phase through MAP-kinase-mediated phosphorylation 18 . We now suggest that Cdt1 stabilization in G2 cells evolved to facilitate its rapid re-accumulation before mitosis. Although yeast Cdt1 is clearly not required for anaphase 34, 35 , metazoan Cdt1 may have acquired its mitotic role as a means of reinforcing the dependence of a key mitotic event on the completion of genome duplication. The acquisition of functions in two different cell-cycle phases has the consequence that de-regulation of Cdt1 has the potential to affect both origin licensing and mitosis, and thus genome stability 36, 37 .
The role of the Hec1 'loop' domain
The presence of high levels of Mad1 at kinetochores of Cdt1-depleted cells or Hec1-Loop MUT -expressing cells indicates that Cdt1 and the loop are required for attachment but not for Mad1 retention, unlike cells lacking Hec1 entirely, in which both attachment and Mad1 retention are defective 28, 29 (data not shown). The globular CH domain and N-terminal tail of Hec1 make direct contacts with microtubules, and the loop domain is not required for high-affinity binding of Ndc80 bonsai complexes to microtubules, a construct lacking the region that includes the loop 38 . It was therefore surprising that mutation of the Hec1 loop domain, a site ∼18 nm along the Hec1 rod domain from these direct microtubule contacts, had such profound negative effects on the formation of stable microtubule attachments. Clearly the formation of robust attachments in vivo requires not only the Hec1 CH domain and N-terminal region, but also Cdt1 interaction with the loop domain.
Recent studies in yeast have shown a requirement for the loop in yeast Hec1/Ndc80 for binding microtubule-binding proteins (MAPs), that is, the Dam1 complex in budding yeast or Dis1/TOG in fission yeast 4, 5 . The amino-acid sequence of the loop is not highly conserved 3 , and human Cdt1 has no detectable sequence homology to Dam1 complex members or to Dis1/TOG. Nevertheless, Cdt1 could serve an analogous function by interacting with microtubules or an as yet, unidentified microtubule-associated protein (Fig. 8e) or alternatively by inhibiting Aurora B-mediated kinetochore-fibre destabilization.
A model for Cdt1-Hec1 interaction in mitosis
The Hec1 loop produces a flexible hinge in the otherwise relatively rigid Ndc80 complex. In the complete absence of microtubules, the average separation, Delta, between the two ends of the Ndc80 complex is only ∼19 nm (ref. 26) in both controls and Cdt1-depleted cells. This average distance extends to ∼41 nm for control metaphase cells when kinetochores achieve a full microtubule complement. In the absence of Cdt1, Ndc80 does not make this full extension, producing Delta measurements ∼68-76% between the two extremes. In contrast, Rod depletion removes the main recruitment factor for the dynein-dynactin complex and disrupts other kMT-binding sites contributed by this microtubule motor 31, 39, 40 . The fact that Ndc80 can adopt the full extended shape in Rod-depleted cells, which, similarly to Cdt1-depleted cells, have unstable kMT attachments 31 , provides evidence against a general indirect effect of attachment on Ndc80 conformation. We propose that Cdt1 physically links the Hec1 loop to the microtubule or a microtubule-associated protein, and this extra attachment stabilizes the extended conformation and enhances the microtubule affinity of the Ndc80 complex provided by the Hec1 CH domain and N-terminal tail. expressing histone H2B) and NHF1-htert cells were cultured in DMEM (Difco or Invitrogen) supplemented with 10% fetal bovine or calf serum (Sigma), 100 U ml −1 penicillin and 100 mg ml −1 streptomycin. LLCPK1 cells were grown in DMEM with 5% FBS and PTK2 cells were cultured in MEM-α medium supplemented with 15% FBS. Transfections were performed with a total of 100 nM of each siRNA duplex using Dharmafect 1 reagent (Dharmacon/Thermo Scientific) according to the manufacturer's guidelines. Stable cell lines expressing Cdt1 have been described previously 18 . Flow cytometric analysis for cell-cycle position was performed as described previously 16 . Synthetic siRNAs: cdt1 siRNA and cdc6 siRNA (ref. 16) were synthesized by Invitrogen/Life Technologies, mad1 siRNA was purchased from Dharmacon (SMART pool catalogue no. L-005825-00-0005), rod siRNA from Dharmacon (SMARTpool catalogue no. L006829-00-0005), hec1(human) siRNA (ref. 28) 5 -AAAAAGAACCGAAUCGUCUAGAA-3 , hec1 siRNA (rat kangaroo) 5 -AAUGAGCCGAAUCGUCUAAUAdTdT-3 and orc6 siRNA (ref. 14) 5 -AAGAUUGGACAGCAGGUCGACUU-3 were synthesized by Dharmacon.
METHODS
Methods
HeLa cells were synchronized by treatment with 2 mM thymidine for 18 h followed by release for 9 h and then re-treatment with 2 mM thymidine for 18 h . Synthetic duplexed RNA oligonucleotides were transfected into HeLa cells according to the manufacturer's instructions. Other cell manipulations include 10 µM nocodazole treatment, 3 µM ZM447439 treatment and cold treatment for 10 min with ice-cold PBS.
Antibodies. Guinea pig anti-Cdt1 is described in ref. 41 (diluted 1:3,000 for immunoblots and 1:100 for immunofluorescence staining); rabbit polyclonal anti-Cdt1 was purchased from Santa Cruz Biotechnology (catalogue no. sc28262). Other primary antibodies used in this study include anti-tubulin monoclonal (1:20,000 for immunoblots and 1:500 for cell staining, Sigma-Aldrich, no. 9026, clone DM1A), anti-dynein IC monoclonal antibodies (1:200 for staining Sigma-Aldrich, no. D5167, clone 70.1), anti-Hec1 (1:6,000 for immunoblots and 1:500 for staining, Abcam, no. ab3613, clone 9G3), Nuf2 (1:5,000 for immunoblots and 1:200 for staining, Abcam no. ab17058, clone 28-37), anti-GFP polyclonal (1:200 for staining, Invitrogen, no. A6455), monoclonal (1:100 for staining, Chemicon/Millipore, no. MAB3580) or monoclonal (1:5,000 for immunoblots, Clontech, Mountain View, no. 632381, clone JL-8), anti-Cdc6 monoclonal (1:1,000 for immunoblots Santa Cruz Biotechnology, no. sc-9964 clone 180.2), anti-geminin polyclonal (1:200 for staining, Santa Cruz Biotechnology, no. sc-13015), anti-phospho-H2A.X(Ser139) (1:1,000 for staining, Millipore, no. 05-636, clone JBW301), anti-Mad1 polyclonal (GeneTex, no. GTX109519). Alexa 488-, Rhodamine Red-X-, Cy5-or HRPlabelled secondary antibodies were obtained from Jackson ImmunoResearch. Orc6 polyclonal antibody (1:200) for staining was a generous gift from B. Stillman; anti-Orc6 for immunoblots (1:1,000) was purchased from Santa Cruz Biotechnology (no. sc-32735, clone 3A4). Immunoblots were scanned into Adobe Photoshop and any manipulations for brightness were applied to the entire image; final figures show cropped regions and the uncropped blots are provided as Supplementary Fig. S9 .
Immunofluorescence microscopy, live-cell imaging and Delta analysis. Cells
were typically fixed for 20 min using 4% paraformaldehyde after permeabilization with 0.5% Triton X-100. For Spc24 staining, 2% paraformaldehyde was used. For dynein IC staining, the cells were fixed for 6 min at −20 • C with ice-cold methanol. Cells were rinsed in PHEM buffer (120 mM PIPES, 50 mM HEPES, 20 mM EGTA and 4 mM magnesium acetate, at pH 6.9) before fixation. All of the antibody incubations and washes were also performed in PHEM buffer plus 0.05% BSA. DAPI staining (0.1 µg ml −1 ) was for 10 min, and cells were mounted using Prolong Antifade (Molecular Probes). All antibody incubations were conducted at 37 • C for 1 h. For image acquisition, three-dimensional stacks were obtained sequentially at 200 nm steps along the z axis through the cell using a high-resolution Nikon confocal microscopy equipped with a Yokogawa CSU10 spinning disc with image magnification yielding a 65 nm pixel size from the camera 42 and a ×100/1.4 NA (Planapo) DIC oil-immersion objective (Nikon). Delta analysis to measure separations at high (nanometre) accuracy between protein epitopes labelled with separate colours was carried out as described previously 26 .
For microinjection, polyclonal anti-Cdt1 antiserum 41 was depleted of antibodies to non-Cdt1 proteins by repeated rounds of incubation with lysates of ultraviolettreated HeLa cells (which lack Cdt1). These antibody preparations were then concentrated by centrifugation using microconcentrators. Anti-Cdt1 antibody, control IgG or buffer were injected into HeLa cells that stably express a GFP fusion to histone H2B either in prometaphase or in metaphase. Injections were carried out on a Zeiss IM microscope equipped with phase optics and a ×40/0.75 NA (Planfluar) objective at 35 • C using a Sage air curtain incubator. Injections were 5% cell volume with a Narishige micromanipulator (Narishige USA). Mitotic progression was monitored by live-cell imaging using both phase-contrast and GFP-histone H2B fluorescence analysis with images acquired every two minutes until the end of the duration of imaging.
For live-cell imaging of Hec1-depleted cells, HeLa cells were plated to 50% confluency in a T25 flask and treated with siRNA to Hec1. At 24 h post-siRNA transfection, cells were trypsinized, counted and the wild-type and mutant Hec1 constructs were electroporated along with mCherry-histone H2B expression plasmid using the Lonza Nucleofector apparatus. At 24 h post-electroporation, cells were imaged by time-lapse microscopy every 4 min for 5 h using a Deltavision PersonalDV Imaging System (Applied Precision) equipped with a Photometrics CoolSnap HQ2 camera and a ×60/1.42 NA (Planapo) DIC oil-immersion lens (Olympus).
Protein-protein interaction assays.
For two-hybrid screening, the full-length human Cdt1 complementary DNA was inserted into pGBT9 (Clontech). Cotransformants of yeast strain PJ69a (ref. 43) with two cDNA fusion libraries (placental cDNA or thymus cDNA, Clontech) were selected on medium containing 10 mM 3-amino-1,2,4 triazole (Sigma). More than 8 million co-transformants of each library were screened; Hec1 clones were identified from both libraries. GST pulldowns and co-immunoprecipitations were performed essentially as described previously 41 . GST-Cdt1 was produced in BL21(DE3) purified on glutathione-Sepharose (GE Healthcare) and incubated with cell lysates prepared in buffer 1 (50 mM HEPES at pH 7.2, 33 mM potassium acetate, 0.5 mM EDTA, 0.5 mM EGTA, 0.1% Nonidet P-40, 10% glycerol, protease and phosphatase inhibitors). Cell lysates were prepared in buffer 1 or a 1:1 mix of buffer 1 and CSK buffer (10 mM PIPES, at pH 7.0, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl 2 plus protease and phosphatase inhibitors), digested with micrococcal nuclease before clarification by centrifugation, and incubated with GST-protein-coated beads for 2 h, or with antibodies for co-immunoprecipitation and protein A beads, washed three times and then released by boiling in SDS-PAGE loading buffer. HeLa cells transfected with control or cdt1 siRNA after release from double thymidine synchronization described in Fig. 1 were harvested at the indicated time points and analyzed for DNA content by flow cytometry and (b) for Cdt1 protein by immunoblotting. (c) HeLa cells stably expressing normal Cdt1 (WT), or an unphosphorylatable derivative with alanine substitutions at positions S391, T402, T406, S411, and S491 (from Chandrasekaran, et. al., 2011) were synchronized in early S by double thymidine block and released into siRNA as described in Fig.1 . Nocodazole was added during S phase to hold cells briefly in early mitosis (0 =10 hrs after thymidine release into nocodazole) and then removed to allow cells to divide (2 hrs). Flow cytometric analysis of DNA content is plotted. (d) Immunoblot analysis of Cdt1 protein; the alanine substitutions block the phosphorylation-induced gel mobility shift. Vector, siRNA controls, and WT Cdt1 data are the same as Fig. 1d . (e) Asynchronous HeLa cells treated with control luciferase, orc6, or cdt1 siRNAs (as indicated) or double thymidine synchronized HeLa cells treated with cdt1 siRNA in S and fixed at 10 hrs after S phase release (right-most panels) were stained with DAPI (pseudo-colored green) and anti-phospho-H2A.X antibody (red). 
si-hec1
Merge w/ ACA Cdt1 Figure S4 Cdt1 and Hec1 interact. (a) A yeast-two-hybrid library screen of proteins interacting with Cdt1 yielded multiple clones of the kinetochore protein Hec1. The diagram illustrates the Hec1 sequences contained in 5 independent clones isolated (some more than once); the location of the loop domain is indicated. (b) Yeast strain PJ69a was transformed with plasmids encoding fusions to the Gal4 DNA binding domain ("Gal4DB") and fusions to the Gal4 transcriptional activation domain ("Gal4AD"). The Hec1 protein sequences included in the fusions are listed in superscript; a Gal4AD fusion to the Cdt1 inhibitor geminin serves as a positive control, and negative controls (empty vectors) are indicated by "0." Serial five-fold dilutions of yeast cultures were spotted onto agar plates containing the indicated concentrations of 3-amino-1,2,4 triazole ("3-AT") to measure transcriptional activation of the GAL4pr-HIS3 interaction reporter and incubated for 3 days at 30°C before photographing. YPD and SCD-UL control plates contained no 3-AT. (c) Metaphase PTK2 cells treated with hec1 siRNA were stained with anti-Cdt1, anti-Hec1 and anti-ACA antibodies. (d) Lysates from HeLa cells treated with siRNA targeting control GFP, Cdt1 or Hec1 were immunoblotted for Cdt1, Hec1 and tubulin. (e) Synchronized HeLa cells subjected to Cdt1 RNAi during S phase for 9 hrs were stained using anti-Hec1 and anti-Zwint1 antibodies. Scale bars = 5 µm.
